Tag: canine arthritis treatment market analysis

Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.

Canine Arthritis Treatment Market Value Analysis: What Growth Lies Ahead Over The Forecast Period?

The canine arthritis treatment market size has witnessed strong expansion in recent years. It is anticipated to grow from $2.47 billion in 2025 to $2.6 billion in 2026, at a compound annual growth rate (CAGR) of 5.4%. This historical growth can be attributed to the increasing prevalence of canine arthritis, heightened awareness among pet owners, innovations in veterinary pharmaceuticals, an expanding dog population, and the proliferation of veterinary clinics and hospitals.

The canine arthritis treatment market is projected to experience consistent expansion in the coming years, reaching a valuation of $3.13 billion by 2030, driven by a compound annual growth rate (CAGR) of 4.7%. This anticipated growth is attributable to several factors, including the advancement of targeted biologic treatments, the rising integration of precision medicine in veterinary practices, breakthroughs in surgical methods for joint repair, the expansion of online and retail veterinary pharmacy services, and increased funding for stem cell and PRP research. Key trends anticipated during this period encompass the growing acceptance of non-steroidal anti-inflammatory drugs (NSAIDs), a greater reliance on joint supplements such as glucosamine and chondroitin, the expansion of stem cell therapy and platelet-rich plasma (PRP) treatments, an increase in minimally invasive surgical options for canines, and the incorporation of physical therapy and cold laser therapy into arthritis management protocols.

Get A Free Sample Report With In-Depth Market Insights:

https://thebusinessresearchcompany.com/sample_request?id=16007&type=smp&name=Canine%20Arthritis%20Treatment%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Canine Arthritis Treatment Market Growth Factors: What’s Supporting Expansion?

The escalating rate of pet ownership is anticipated to stimulate the advancement of the canine arthritis treatment market in the foreseeable future. Pet ownership encompasses the responsibility and care undertaken by individuals or households in catering to the necessities, well-being, and companionship of domesticated animals kept primarily for pleasure rather than practical purposes. This increase in pet ownership is driven by factors such as shifts in lifestyle, the humanization of pets, and elevated disposable incomes. Pet owners utilize canine arthritis treatments to control and ease the manifestations of arthritis in their dogs, with the goal of enhancing their pets’ quality of life and sustaining their mobility. For example, in April 2025, the Canadian Animal Health Institute, a Canada-based trade association, indicated that in 2024, Canada housed an estimated 7.2 million dogs and 8.2 million cats, demonstrating that pets are a vital component of more than half of Canadian households. Therefore, the growing pet ownership rate is a key factor propelling the expansion of the canine arthritis treatment market.

Canine Arthritis Treatment Market Segments: Where Is Growth Concentrated?

The canine arthritis treatment market covered in this report is segmented –

1) By Treatment Type: Drugs, Supplements, Surgical Procedures, Other Treatment Types

2) By Route Of Administration: Oral, Parenteral, Other Routes Of Administrations

3) By Arthritis Type: Osteoarthritis, Rheumatoid Arthritis, Osteochondrosis, Traumatic Arthritis

4) By Distribution Channels: Veterinary Clinics And Hospitals, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By Drugs: Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Disease-Modifying Osteoarthritis Drugs (DMOADs), Corticosteroids, Analgesics And Pain Relievers

2) By Supplements: Glucosamine And Chondroitin Supplements, Omega-3 Fatty Acids And Fish Oil, Hyaluronic Acid Supplements, MSM (Methylsulfonylmethane) Supplements, Collagen-Based Supplements

3) By Surgical Procedures: Joint Replacement Surgery, Arthroscopy, Osteotomy, Synovectomy

4) By Other Treatment Types: Physical Therapy, Stem Cell Therapy, Platelet-Rich Plasma (PRP) Therapy, Cold Laser Therapy (Low-Level Laser Therapy), Acupuncture

Canine Arthritis Treatment Market Industry Trends: What’s Reshaping Demand?

Leading firms within the canine arthritis treatment market are introducing novel therapies, specifically bedinvetmab injections, aimed at improving canine joint health and overall mobility. Bedinvetmab, a type of monoclonal antibody injection, functions by specifically targeting and deactivating nerve growth factor (NGF), which is a protein linked to pain in veterinary applications. For example, during May 2023, the US-based animal health corporation, Zoetis Inc., obtained approval from the Food and Drug Administration (FDA) for its product Librela, which is a bedinvetmab injection. This product marks the FDA’s initial approval of a monoclonal antibody (mAb) for canine use, operating by binding to and suppressing the biological effects of canine nerve growth factor (NGF), a key component in regulating pain linked to OA. Administered via subcutaneous injection just once a month, it presents a convenient and enduring option for managing osteoarthritic pain in dogs.

Canine Arthritis Treatment Market Key Players Shaping Industry Direction

Major companies operating in the canine arthritis treatment market are Merck & Co. Inc., Bayer AG, Eli Lilly and Company, Zoetis Inc., Boehringer Ingelheim Animal Health, Elanco Animal Health Incorporated, Royal Canin SAS, Virbac Group, Ceva Sante Animale S.A., Hill’s Pet Nutrition Inc., Vetoquinol SA, Norbrook Laboratories Limited, American Regent Inc., Thorne Healthtech Inc., VetStem Inc., Eltech K-Laser s.r.l., Liquid Health Inc, Nutri-Vet LLC, OrthoPets LLC, Rejuvenate Bio Inc.

View The Full Canine Arthritis Treatment Market Report:

https://thebusinessresearchcompany.com/report/canine-arthritis-treatment-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Canine Arthritis Treatment Market Regional Analysis: Which Geography Leads On Revenue?

North America was the largest region in the canine arthritis treatment market in 2025. Asia-Pacifica is expected to be the fastest-growing region in the forecast period. The regions covered in the canine arthritis treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Reach Out To Our Team:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Market Size Of The Allergic Rhinitis Drugs Market In 2026 And What Value Is Projected For 2030?

The canine arthritis treatment market size has experienced significant growth over recent years. This market is projected to expand from $2.47 billion in 2025 to $2.6 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 5.4%. Historically, this expansion has been driven by factors including the increasing prevalence of canine arthritis, enhanced awareness among pet owners, progress in veterinary pharmaceuticals, an expanding dog population, and the proliferation of veterinary clinics and hospitals.

The market for canine arthritis treatment is projected to experience consistent expansion over the upcoming years. It is anticipated to reach $3.13 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 4.7%. This expansion during the projection period stems from factors such as the advancement of targeted biologic treatments, the wider adoption of precision medicine in veterinary practices, breakthroughs in surgical methods for joint repair, the proliferation of online and physical veterinary pharmacies, and increased funding for stem cell and PRP research. Key developments anticipated in this period encompass the growing preference for non-steroidal anti-inflammatory drugs (NSAIDs), a rise in the application of joint supplements like glucosamine and chondroitin, an increase in stem cell therapy and platelet-rich plasma (PRP) interventions, the wider availability of minimally invasive surgical procedures for dogs, and the incorporation of physical therapy and cold laser therapy into arthritis management protocols.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16007&type=smp

What Major Drivers Are Influencing Demand In The Allergic Rhinitis Drugs Market?

The anticipated expansion of the **canine arthritis treatment market** going forward is significantly propelled by the increasing rate of pet ownership. Pet ownership involves the responsibility and care individuals or households provide for the needs, well-being, and companionship of domesticated animals kept primarily for pleasure rather than utility. This surge in pet ownership is attributed to evolving lifestyle changes, the humanization of pets, and higher disposable incomes. Pet owners employ **canine arthritis treatments** to manage and alleviate the symptoms of arthritis in their dogs, with the goal of improving their pets’ quality of life and sustaining mobility. For instance, in **April 2025**, data from the **Canadian Animal Health Institute**, a **Canada**-based trade association, revealed that in **2024**, **Canada** housed an estimated **7.2 million dogs** and **8.2 million cats**, signifying that pets are a vital component of more than **half of Canadian households**. Hence, the escalating pet ownership rate is a primary driver for the growth of the **canine arthritis treatment market**.

What Are The Key Segments Of The Allergic Rhinitis Drugs Market?

The canine arthritis treatment market covered in this report is segmented –

1) By Treatment Type: Drugs, Supplements, Surgical Procedures, Other Treatment Types

2) By Route Of Administration: Oral, Parenteral, Other Routes Of Administrations

3) By Arthritis Type: Osteoarthritis, Rheumatoid Arthritis, Osteochondrosis, Traumatic Arthritis

4) By Distribution Channels: Veterinary Clinics And Hospitals, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By Drugs: Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Disease-Modifying Osteoarthritis Drugs (DMOADs), Corticosteroids, Analgesics And Pain Relievers

2) By Supplements: Glucosamine And Chondroitin Supplements, Omega-3 Fatty Acids And Fish Oil, Hyaluronic Acid Supplements, MSM (Methylsulfonylmethane) Supplements, Collagen-Based Supplements

3) By Surgical Procedures: Joint Replacement Surgery, Arthroscopy, Osteotomy, Synovectomy

4) By Other Treatment Types: Physical Therapy, Stem Cell Therapy, Platelet-Rich Plasma (PRP) Therapy, Cold Laser Therapy (Low-Level Laser Therapy), Acupuncture

What Key Trends Are Influencing The Development Of The Canine Arthritis Treatment Market?

Leading companies in the canine arthritis treatment market are developing innovative therapies, such as bedinvetmab injections, to address canine joint health and mobility. Bedinvetmab is a monoclonal antibody injection that functions by targeting and neutralizing nerve growth factor (NGF), a protein linked to pain in veterinary medicine. For instance, in May 2023, Zoetis Inc., a US-based animal health company, received approval from the Food and Drug Administration (FDA) for Librela, a bedinvetmab injection. This marks the first monoclonal antibody (mAb) approved by the FDA for canine use, working by binding to and inhibiting the biological activity of canine nerve growth factor (NGF), which plays a role in regulating pain associated with OA. Administered via subcutaneous injection once a month, it offers a convenient and long-term solution for managing canine OA pain.

Who Are The Leading Companies Operating In The Allergic Rhinitis Drugs Market?

Major companies operating in the canine arthritis treatment market are Merck & Co. Inc., Bayer AG, Eli Lilly and Company, Zoetis Inc., Boehringer Ingelheim Animal Health, Elanco Animal Health Incorporated, Royal Canin SAS, Virbac Group, Ceva Sante Animale S.A., Hill’s Pet Nutrition Inc., Vetoquinol SA, Norbrook Laboratories Limited, American Regent Inc., Thorne Healthtech Inc., VetStem Inc., Eltech K-Laser s.r.l., Liquid Health Inc, Nutri-Vet LLC, OrthoPets LLC, Rejuvenate Bio Inc.

Read the full canine arthritis treatment market report here:

https://www.thebusinessresearchcompany.com/report/canine-arthritis-treatment-global-market-report

Which Region Shows The Strongest Potential For Future Growth In The Allergic Rhinitis Drugs Market?

North America was the largest region in the canine arthritis treatment market in 2025. Asia-Pacifica is expected to be the fastest-growing region in the forecast period. The regions covered in the canine arthritis treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Allergic Rhinitis Drugs Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=16007&type=smp

Browse Through More Reports Similar to the Global Canine Arthritis Treatment Market 2026, By The Business Research Company

Companion Animal Arthritis Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/companion-animal-arthritis-global-market-report

Veterinary Orthopedic Medicine Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/veterinary-orthopedic-medicine-global-market-report

Veterinary Pain Management Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/veterinary-pain-management-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the artificial intelligence (ai) safety market from 2026–2035 with trusted insights from The Business Research Company

What level of CAGR-driven expansion is anticipated in the Canine Arthritis Treatment Market between 2026 and 2030?

The canine arthritis treatment market has experienced robust growth recently. This market is projected to expand from $2.47 billion in 2025 to $2.6 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 5.4%. Historically, this expansion has been driven by factors such as the increasing occurrence of canine arthritis, heightened awareness among pet owners, progress in veterinary pharmaceutical products, a growing dog population, and the proliferation of veterinary clinics and hospitals.

The market size for canine arthritis treatment is predicted to show consistent growth over the next few years, reaching $3.13 billion by 2030 with a compound annual growth rate (CAGR) of 4.7%. This expansion during the forecast period is driven by factors such as the development of targeted biologic therapies, increased integration of precision medicine in veterinary practices, advancements in surgical techniques for joint repair, the expansion of online and retail veterinary pharmacies, and greater investment in stem cell and PRP research. Key trends expected in the forecast period include the increasing adoption of non-steroidal anti-inflammatory drugs (NSAIDs), a rise in the utilization of joint supplements like glucosamine and chondroitin, the growth of both stem cell therapy and platelet-rich plasma (PRP) treatments, an expansion of minimally invasive surgical procedures for dogs, and the integration of physical therapy and cold laser therapy into arthritis management.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16007&type=smp

What Drivers Are Affecting Demand-Supply Dynamics In The Canine Arthritis Treatment Market?

An anticipated increase in pet ownership is projected to drive expansion within the canine arthritis treatment market. Pet ownership encompasses the accountability and nurture exhibited by individuals or families when attending to the requirements, welfare, and companionship of domesticated animals primarily kept for enjoyment rather than practical use. This upward trend in pet ownership is attributable to various elements, including evolving lifestyles, the increasing humanization of companion animals, and enhanced disposable incomes. Owners utilize treatments for canine arthritis to manage and mitigate arthritic symptoms in their dogs, with the objective of enhancing their pets’ overall quality of life and preserving their ability to move. A notable example cited in April 2025 by the Canadian Animal Health Institute, a Canada-based trade association, revealed that in 2024, Canada harbored an estimated 7.2 million dogs and 8.2 million cats, signifying that pets constitute an essential component of more than half of Canadian households. Consequently, the increasing rate of pet ownership is serving as a catalyst for the expansion of the canine arthritis treatment market.

How Is The Canine Arthritis Treatment Market Organized Into Various Segments?

The canine arthritis treatment market covered in this report is segmented –

1) By Treatment Type: Drugs, Supplements, Surgical Procedures, Other Treatment Types

2) By Route Of Administration: Oral, Parenteral, Other Routes Of Administrations

3) By Arthritis Type: Osteoarthritis, Rheumatoid Arthritis, Osteochondrosis, Traumatic Arthritis

4) By Distribution Channels: Veterinary Clinics And Hospitals, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By Drugs: Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Disease-Modifying Osteoarthritis Drugs (DMOADs), Corticosteroids, Analgesics And Pain Relievers

2) By Supplements: Glucosamine And Chondroitin Supplements, Omega-3 Fatty Acids And Fish Oil, Hyaluronic Acid Supplements, MSM (Methylsulfonylmethane) Supplements, Collagen-Based Supplements

3) By Surgical Procedures: Joint Replacement Surgery, Arthroscopy, Osteotomy, Synovectomy

4) By Other Treatment Types: Physical Therapy, Stem Cell Therapy, Platelet-Rich Plasma (PRP) Therapy, Cold Laser Therapy (Low-Level Laser Therapy), Acupuncture

What Trends Are Expected To Impact The Competitive Landscape Of The Canine Arthritis Treatment Market?

Leading companies operating in the canine arthritis treatment market are introducing innovative therapies, such as bedinvetmab injections, to enhance canine joint health and mobility. Bedinvetmab is a monoclonal antibody injection designed to target and neutralize nerve growth factor (NGF), a protein associated with pain, commonly employed in veterinary medicine. For example, in May 2023, Zoetis Inc., a US-based animal health company, secured approval from the Food and Drug Administration (FDA) for Librela, a bedinvetmab injection. This product marks the first monoclonal antibody (mAb) approved by the FDA for use in dogs, functioning by binding to and inhibiting the biological activity of canine nerve growth factor (NGF), which plays a role in regulating pain linked to OA. Administered once a month via subcutaneous injection, it offers a convenient and enduring option for managing canine OA pain.

Who Are The Major Companies Operating In The Canine Arthritis Treatment Market?

Major companies operating in the canine arthritis treatment market are Merck & Co. Inc., Bayer AG, Eli Lilly and Company, Zoetis Inc., Boehringer Ingelheim Animal Health, Elanco Animal Health Incorporated, Royal Canin SAS, Virbac Group, Ceva Sante Animale S.A., Hill’s Pet Nutrition Inc., Vetoquinol SA, Norbrook Laboratories Limited, American Regent Inc., Thorne Healthtech Inc., VetStem Inc., Eltech K-Laser s.r.l., Liquid Health Inc, Nutri-Vet LLC, OrthoPets LLC, Rejuvenate Bio Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/canine-arthritis-treatment-global-market-report

Which Region Is Anticipated To See The Fastest Growth In The Canine Arthritis Treatment Market?

North America was the largest region in the canine arthritis treatment market in 2025. Asia-Pacifica is expected to be the fastest-growing region in the forecast period. The regions covered in the canine arthritis treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Canine Arthritis Treatment Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=16007&type=smp

Browse Through More Reports Similar to the Global Canine Arthritis Treatment Market 2026, By The Business Research Company

Companion Animal Arthritis Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/companion-animal-arthritis-global-market-report

Veterinary Orthopedic Medicine Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/veterinary-orthopedic-medicine-global-market-report

Veterinary Pain Management Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/veterinary-pain-management-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Uncover key drivers, emerging technologies, and competitive movements shaping the canine arthritis treatment market from 2025–2034 with trusted insights from The Business Research Company

What CAGR And Valuation Are Anticipated For The Canine Arthritis Treatment Market By The End Of 2029?

The sector dedicated to treating canine arthritis has experienced significant expansion lately, projecting an advancement from its 2024 valuation of $2.35 billion to $2.47 billion by 2025, translating to a compound annual growth rate of 5.3 during that span. This upward trajectory observed during the review period is fundamentally supported by several factors, including the increasing prevalence of older dogs, heightened consciousness among those who own pets regarding treatment options, a greater emphasis placed on prophylactic health measures, rising levels of discretionary spending, and greater overall spending on veterinary services.

Projected for substantial expansion in the forthcoming years, the market dedicated to treating arthritis in dogs is anticipated to reach a valuation of $3.01 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 5.0%; this upward trajectory during the projection timeframe is fundamentally supported by several factors, including the wider acceptance of pet insurance policies, an increasing incidence of arthritic conditions in dogs, escalating rates of pet humanization and ownership, the heightened need for surgical interventions that involve less tissue trauma, and the general increase in the frequency of this ailment among the canine population, while key developments shaping this sector involve the introduction of novel therapeutic modalities, progressive strides within veterinary science, a strong market pull for sophisticated treatment options, the incorporation of modern technological tools, and the emergence of state-of-the-art innovations.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16007&type=smp

Which Business Drivers Are Underpinning The Growth Of The Canine Arthritis Treatment Market?

Advancements in the number of individuals maintaining companion animals are projected to be a key force driving the expansion of the market for canine arthritis therapeutics hereafter. This concept of pet ownership encompasses the commitment and provisioning made by individuals or family units to ensure the welfare, necessities, and companionship for domesticated creatures kept mainly for enjoyment rather than practical service. Several elements, including shifts in living patterns, the increasing tendency to treat pets as family members, and greater amounts of discretionary funds, contribute to the upward trend in pet possession statistics. Guardians procure canine joint affliction therapies to effectively control and lessen the discomfort associated with arthritis in their dogs, their objective being to enhance their animal companions’ living standards and preserve their capacity to move freely. To illustrate this point, data released in October 2023 by the American Pet Products Association, a US-based organization operating on a non-profit basis, indicated that 86.9 million households across the United States harbored a pet, reflecting an ownership rate of 66% compared to the figures from 2022, consequently, this surge in household pet retention is fueling momentum in the market for canine arthritis remedies.

What Are The Principal Segment Types In The Canine Arthritis Treatment Market?

The canine arthritis treatment market covered in this report is segmented –

1) By Treatment Type: Drugs, Supplements, Surgical Procedures, Other Treatment Types

2) By Route Of Administration: Oral, Parenteral, Other Routes Of Administrations

3) By Arthritis Type: Osteoarthritis, Rheumatoid Arthritis, Osteochondrosis, Traumatic Arthritis

4) By Distribution Channels: Veterinary Clinics And Hospitals, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By Drugs: Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Disease-Modifying Osteoarthritis Drugs (DMOADs), Corticosteroids, Analgesics And Pain Relievers

2) By Supplements: Glucosamine And Chondroitin Supplements, Omega-3 Fatty Acids And Fish Oil, Hyaluronic Acid Supplements, MSM (Methylsulfonylmethane) Supplements, Collagen-Based Supplements

3) By Surgical Procedures: Joint Replacement Surgery, Arthroscopy, Osteotomy, Synovectomy

4) By Other Treatment Types: Physical Therapy, Stem Cell Therapy, Platelet-Rich Plasma (PRP) Therapy, Cold Laser Therapy (Low-Level Laser Therapy), Acupuncture

How Are Industry Trends Steering The Expansion Of The Canine Arthritis Treatment Market?

Leading enterprises within the veterinary arthritis sector are innovating therapeutic avenues, exemplified by the creation of bedinvetmab injections, specifically aimed at enhancing canine joint function and movement. This bedinvetmab preparation constitutes a monoclonal antibody delivered via injection, functioning through the identification and neutralization of nerve growth factor (NGF), a protein recognized for its role in transmitting pain within animal healthcare contexts. To illustrate, in May of 2023, Zoetis Inc., a prominent animal health corporation headquartered in the United States, secured authorization from the Food and Drug Administration (FDA) for Librela, this very bedinvetmab injectable product. It holds the distinction of being the inaugural monoclonal antibody (mAb) endorsed by the FDA for canine application, achieving its effect by attaching to and suppressing the biological pathways of canine nerve growth factor (NGF), which plays a part in governing the discomfort linked to osteoarthritis. Administration involves a monthly subcutaneous shot, positioning it as a straightforward and sustained approach for managing the persistent pain experienced by dogs suffering from osteoarthritis.

Which Companies Are Contributing Significantly To The Canine Arthritis Treatment Market Growth?

Major companies operating in the canine arthritis treatment market are Merck & Co. Inc., Bayer AG, Eli Lilly and Company, Zoetis Inc., Boehringer Ingelheim Animal Health, Elanco Animal Health Incorporated, Royal Canin SAS, Virbac Group, Ceva Sante Animale S.A., Hill’s Pet Nutrition Inc., Vetoquinol SA, Norbrook Laboratories Limited, American Regent Inc., Thorne Healthtech Inc., VetStem Inc., Eltech K-Laser s.r.l., Liquid Health Inc, Nutri-Vet LLC, OrthoPets LLC, Rejuvenate Bio Inc.

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/canine-arthritis-treatment-global-market-report

Which Region Offers The Most Opportunity For Canine Arthritis Treatment Market Expansion?

North America was the largest region in the canine arthritis treatment market in 2024. Asia-Pacifica is expected to be the fastest-growing region in the forecast period. The regions covered in the canine arthritis treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=16007&type=smp

Browse Through More Reports Similar to the Global Canine Arthritis Treatment Market 2025, By The Business Research Company

Fertility Treatments Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/fertility-treatments-global-market-report

Polycystic Ovarian Syndrome Treatment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/polycystic-ovarian-syndrome-treatment-global-market-report

Alzheimer Disease Treatment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/alzheimer-disease-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

How Much Was The Canine Arthritis Treatment Market Worth In 2025, And What Is Its Anticipated Value By 2029?

The market for canine arthritis treatment has experienced robust expansion in recent times. Projections indicate it will expand from $2.35 billion in 2024 to $2.47 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 5.3%. Factors contributing to this historical expansion include an aging pet population, heightened awareness among pet owners, an emphasis on preventive care, rising disposable income, and increased spending on veterinary services.

The canine arthritis treatment market is projected to experience robust expansion over the coming years, anticipated to reach $3.01 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 5.0%. Factors contributing to this growth during the projection period include increased pet insurance adoption, a rise in arthritis diagnoses, higher rates of pet ownership, an increasing need for less invasive surgical options, and the rising occurrence of arthritis among dogs. Significant trends expected in the forecast timeframe encompass novel treatments, progress in veterinary medicine, a call for sophisticated therapies, technological integration, and cutting-edge innovations.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16007&type=smp

What Are The Main Drivers Boosting The Canine Arthritis Treatment Industry’s Expansion?

Increased pet ownership is projected to drive the expansion of the canine arthritis treatment market moving forward. Pet ownership involves the care and responsibility undertaken by individuals or households in providing for the companionship, well-being, and needs of domesticated animals kept mainly for enjoyment rather than for practical use. The increase in pet ownership rates stems from factors such as lifestyle adjustments, the humanization of pets, and higher disposable incomes. Pet owners utilize canine arthritis treatments to alleviate and manage arthritis symptoms in their dogs, with the goal of improving their pets’ quality of life and maintaining mobility. For instance, in October 2023, according to the American Pet Products Association, a US-based non-profit association, there were 86.9 million US households that owned a pet, which constituted 66% of households in 2022. Consequently, the rising pet ownership rate is a key driver for the growth of the canine arthritis treatment market.

How Is The Canine Arthritis Treatment Market Classified Into Different Segments?

The canine arthritis treatment market covered in this report is segmented –

1) By Treatment Type: Drugs, Supplements, Surgical Procedures, Other Treatment Types

2) By Route Of Administration: Oral, Parenteral, Other Routes Of Administrations

3) By Arthritis Type: Osteoarthritis, Rheumatoid Arthritis, Osteochondrosis, Traumatic Arthritis

4) By Distribution Channels: Veterinary Clinics And Hospitals, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By Drugs: Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Disease-Modifying Osteoarthritis Drugs (DMOADs), Corticosteroids, Analgesics And Pain Relievers

2) By Supplements: Glucosamine And Chondroitin Supplements, Omega-3 Fatty Acids And Fish Oil, Hyaluronic Acid Supplements, MSM (Methylsulfonylmethane) Supplements, Collagen-Based Supplements

3) By Surgical Procedures: Joint Replacement Surgery, Arthroscopy, Osteotomy, Synovectomy

4) By Other Treatment Types: Physical Therapy, Stem Cell Therapy, Platelet-Rich Plasma (PRP) Therapy, Cold Laser Therapy (Low-Level Laser Therapy), Acupuncture

What Trends Are Expected To Drive The Canine Arthritis Treatment Market?

Leading companies in the canine arthritis treatment market are advancing innovative therapies, such as bedinvetmab injections, to enhance canine joint health and mobility. Bedinvetmab is a monoclonal antibody injection designed to target and neutralize nerve growth factor (NGF), a protein implicated in pain within veterinary medicine. For instance, in May 2023, the US-based animal health firm, Zoetis Inc., obtained approval from the Food and Drug Administration (FDA) for Librela, a bedinvetmab injection. This marks the FDA’s initial approval of a monoclonal antibody (mAb) for use in dogs; it functions by binding to and inhibiting the biological activity of canine nerve growth factor (NGF), which is involved in regulating pain associated with OA. Administered as a subcutaneous injection once a month, it offers a convenient and lasting solution for managing canine OA pain.

Who Are The Core Companies Influencing The Canine Arthritis Treatment Market Landscape?

Major companies operating in the canine arthritis treatment market are Merck & Co. Inc., Bayer AG, Eli Lilly and Company, Zoetis Inc., Boehringer Ingelheim Animal Health, Elanco Animal Health Incorporated, Royal Canin SAS, Virbac Group, Ceva Sante Animale S.A., Hill’s Pet Nutrition Inc., Vetoquinol SA, Norbrook Laboratories Limited, American Regent Inc., Thorne Healthtech Inc., VetStem Inc., Eltech K-Laser s.r.l., Liquid Health Inc, Nutri-Vet LLC, OrthoPets LLC, Rejuvenate Bio Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/canine-arthritis-treatment-global-market-report

Which Global Regions Are Influencing The Competitive Landscape Of The Canine Arthritis Treatment Market?

North America was the largest region in the canine arthritis treatment market in 2024. Asia-Pacifica is expected to be the fastest-growing region in the forecast period. The regions covered in the canine arthritis treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Canine Arthritis Treatment Market Report:

https://www.thebusinessresearchcompany.com/customise?id=16007&type=smp

Browse Through More Reports Similar to the Global Canine Arthritis Treatment Market 2025, By The Business Research Company

Fertility Treatments Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/fertility-treatments-global-market-report

Polycystic Ovarian Syndrome Treatment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/polycystic-ovarian-syndrome-treatment-global-market-report

Alzheimer Disease Treatment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/alzheimer-disease-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Are the Projected Market Size and Growth Rates for the Canine Arthritis Treatment Market From 2025 To 2029?

There has been notable growth in recent years in the market size for canine arthritis treatment. The market, which stood at $2.35 billion in 2024, is projected to expand to $2.47 billion in 2025, with a compound annual growth rate (CAGR) of 5.3%. Factors contributing to the growth during the historic period include a rise in the elderly pet population, heightened awareness among pet owners, emphasis on preventive care, a surge in disposable income, and increased spending on veterinary care.

The market size for canine arthritis treatments is predicted to witness substantial expansion in the ensuing years. With an anticipated expansion to $3.01 billion in 2029 and a compound annual growth rate (CAGR) of 5.0%, this growth in the projected period can be credited to an increased pet insurance coverage, a surge in arthritis cases, a growth in pet ownership, a rising demand for minimally invasive surgeries, and an uptick in the incidence of arthritis in canines. Key trends for the forecast period incorporate cutting-edge therapies, progressions in veterinary medicine, a demand for advanced treatment options, technological integration, and groundbreaking technologies.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16007&type=smp

What are the Fundamental Drivers and Innovations Shaping the Canine Arthritis Treatment Market?

Advancements in the market for canine arthritis treatment are projected to be boosted by the increased rates of pet ownership. The term “pet ownership” defines the dedication and nurturing provided by individuals or households to meet the requirements, health, and companionship of domesticated animals, mainly kept for enjoyment rather than function. The climb in pet ownership can be linked to factors such as changes in lifestyle, the perception of pets as family members, and augmented disposable income. Canine arthritis treatments are employed by pet owners in order to manage and soothe arthritis symptoms in their dogs, with the goal of enhancing the quality of life and preserving agility in their pets. For example, data from the American Pet Products Association, a non-profit organization based in the U.S., reported that there were 86.9 million US households that owned a pet, equating to 66% of households in 2022, by October 2023. As such, the escalation in pet ownership rates is spurring the growth of the canine arthritis treatment market.

How Is the Canine Arthritis Treatment Market Segmented?

The canine arthritis treatment market covered in this report is segmented –

1) By Treatment Type: Drugs, Supplements, Surgical Procedures, Other Treatment Types

2) By Route Of Administration: Oral, Parenteral, Other Routes Of Administrations

3) By Arthritis Type: Osteoarthritis, Rheumatoid Arthritis, Osteochondrosis, Traumatic Arthritis

4) By Distribution Channels: Veterinary Clinics And Hospitals, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By Drugs: Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Disease-Modifying Osteoarthritis Drugs (DMOADs), Corticosteroids, Analgesics And Pain Relievers

2) By Supplements: Glucosamine And Chondroitin Supplements, Omega-3 Fatty Acids And Fish Oil, Hyaluronic Acid Supplements, MSM (Methylsulfonylmethane) Supplements, Collagen-Based Supplements

3) By Surgical Procedures: Joint Replacement Surgery, Arthroscopy, Osteotomy, Synovectomy

4) By Other Treatment Types: Physical Therapy, Stem Cell Therapy, Platelet-Rich Plasma (PRP) Therapy, Cold Laser Therapy (Low-Level Laser Therapy), Acupuncture

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=16007&type=smp

Which Regions Are Driving the Next Phase of the Canine Arthritis Treatment Market Growth?

North America was the largest region in the canine arthritis treatment market in 2024. Asia-Pacifica is expected to be the fastest-growing region in the forecast period. The regions covered in the canine arthritis treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Key Trends Are Shaping the Future of the Canine Arthritis Treatment Market?

Leading businesses in the canine arthritis treatment industry are pioneering new therapies, for example, bedinvetmab injections, to manage joint health and mobility in dogs. Bedinvetmab is an injection of monoclonal antibody that mitigates nerve growth factor (NGF) – a protein that is significant in pain management in veterinary medicine. Zoetis Inc., an animal health enterprise based in the US, earned the approval from the Food and Drug Administration (FDA) for Librela, a bedinvetmab injection in May 2023. This is the first FDA approved monoclonal antibody (mAb) for dog use restraining the biological functioning of the nerve growth factor (NGF), which is a key regulator in OA-associated pain. The treatment is a user-friendly, monthly subcutaneous injection, offering a durable resolution for the pain management in canine OA.

View the full report here:

https://www.thebusinessresearchcompany.com/report/canine-arthritis-treatment-global-market-report

How Is the Canine Arthritis Treatment Market Defined and What Are Its Core Parameters?

Canine arthritis treatment refers to the medical and therapeutic approaches for canine arthritis disease, a chronic condition characterized by inflammation and progressive deterioration of the cartilage within a dog’s joints. It is used to reduce pain and inflammation, maintain joint function, and slow the progression of the disease in dogs.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16007

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Estimated Market Size of the Canine Arthritis Treatment Market In 2029?

Over the past few years, there has been significant growth in the market size for canine arthritis treatment. The market is projected to expand from $2.35 billion in 2024 to $2.48 billion in 2025, with a compound annual growth rate (CAGR) of 5.6%. Factors contributing to the growth during the historic period include the ageing pet population, heightened awareness among pet owners, emphasis on preventive care, boosted disposable income, and a rise in the expenditure on veterinary care.

What Growth Rate Is Forecasted for the Canine Arthritis Treatment Market by 2029?

The anticipated growth of the canine arthritis treatment market is strong for the coming years, with a predicted size of $3.06 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 5.4%. A surge in pet insurance coverage, an increase in arthritis cases, a rise in the number of pet owners, the demand for minimally invasive surgeries, along with the growing occurrence of arthritis in dogs are key factors propelling this growth during the projected period. The market trends during this time are anticipated to be innovations in treatment, advancements in veterinary medicine, a requirement for advanced therapies, the incorporation of technology, and novel technologies.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16007&type=smp

Which Key Companies Are Shaping the Future of the Canine Arthritis Treatment Market?

Major companies operating in the canine arthritis treatment market are Merck & Co. Inc., Bayer AG, Eli Lilly and Company, Zoetis Inc., Boehringer Ingelheim Animal Health, Elanco Animal Health Incorporated, Royal Canin SAS, Virbac Group, Ceva Sante Animale S.A., Hill’s Pet Nutrition Inc., Vetoquinol SA, Norbrook Laboratories Limited, American Regent Inc., Thorne Healthtech Inc., VetStem Inc., Eltech K-Laser s.r.l., Liquid Health Inc, Nutri-Vet LLC, OrthoPets LLC, Rejuvenate Bio Inc.

Which Factors Are Driving Demand in the Canine Arthritis Treatment Industry?

The growth of the canine arthritis treatment market is poised to be driven by the increasing rate of pet ownership. The concept of pet ownership entails the obligation and care provided by individuals or families to attend to the necessities, well-being, and companionship of domesticated animals that are primarily kept for enjoyment rather than utility. The upward trend in pet ownership is attributed to factors such as changes in lifestyle, the anthropomorphization of pets, and elevated disposable incomes. Pet owners employ treatments for canine arthritis to manage and lessen the symptoms of arthritis in their dogs with the goal of enhancing their pets’ quality of life and preserving mobility. For example, in October 2023, the American Pet Products Association, a non-profit association based in the US, reported that there were 86.9 million US households with a pet, accounting for 66% of households in 2022. Consequently, the escalating rate of pet ownership is fueling the expansion of the canine arthritis treatment market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=16007&type=smp

How Is the Canine Arthritis Treatment Market Segmented by Several Divisions?

The canine arthritis treatment market covered in this report is segmented –

1) By Treatment Type: Drugs, Supplements, Surgical Procedures, Other Treatment Types

2) By Route Of Administration: Oral, Parenteral, Other Routes Of Administrations

3) By Arthritis Type: Osteoarthritis, Rheumatoid Arthritis, Osteochondrosis, Traumatic Arthritis

4) By Distribution Channels: Veterinary Clinics And Hospitals, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By Drugs: Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Disease-Modifying Osteoarthritis Drugs (DMOADs), Corticosteroids, Analgesics And Pain Relievers

2) By Supplements: Glucosamine And Chondroitin Supplements, Omega-3 Fatty Acids And Fish Oil, Hyaluronic Acid Supplements, MSM (Methylsulfonylmethane) Supplements, Collagen-Based Supplements

3) By Surgical Procedures: Joint Replacement Surgery, Arthroscopy, Osteotomy, Synovectomy

4) By Other Treatment Types: Physical Therapy, Stem Cell Therapy, Platelet-Rich Plasma (PRP) Therapy, Cold Laser Therapy (Low-Level Laser Therapy), Acupuncture

What are the Emerging Market Trends Driving the Growth of the Canine Arthritis Treatment Industry?

Top players in the canine arthritis treatment market are pioneering novel therapies, such as bedinvetmab injections, to tackle issues related to dog joint health and mobility. Bedinvetmab, a monoclonal antibody injection, operates by identifying and neutralizing nerve growth factor (NGF), a pain-related protein utilized in veterinary medicine. For example, Zoetis Inc., an American animal health firm, in May 2023 gained approval from the Food and Drug Administration (FDA) for Librela, an injection of bedinvetmab. This is the first-ever monoclonal antibody (mAb) receiving FDA’s sanction for usage in dogs and it functions by binding and suppressing the biological function of canine nerve growth factor (NGF), which plays a key role in managing pain associated with OA. It can be given via a subcutaneous injection every month, marking it as a handy and enduring solution for managing the pain of canine OA.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/canine-arthritis-treatment-global-market-report

Which Regions Are Driving Growth in the Canine Arthritis Treatment Market?

North America was the largest region in the canine arthritis treatment market in 2024. Asia-Pacifica is expected to be the fastest-growing region in the forecast period. The regions covered in the canine arthritis treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16007

This Report Delivers Insight On:

1. How big is the canine arthritis treatment market, and how is it changing globally?

2. Who are the major companies in the canine arthritis treatment market, and how are they performing?

3. What are the key opportunities and risks in the canine arthritis treatment market right now?

4. Which products or customer segments are growing the most in the canine arthritis treatment market?

5. What factors are helping or slowing down the growth of the canine arthritis treatment market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Discover trends, market shifts, and competitive outlooks for the canine arthritis treatment industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

What Are the Key Projections for the CAGR of the Canine Arthritis Treatment Market Size From 2025 to 2034?

In recent times, the market size for canine arthritis treatment has consistently seen robust growth. It is projected to expand from $2.35 billion in 2024 to $2.48 billion in 2025, marking a compound annual growth rate (CAGR) of 5.6%. Factors such as the rise in the elderly pet population, heightened knowledge amongst pet owners, focus on preventive healthcare, growth in disposable income, and escalating expenses in veterinary healthcare have contributed significantly to the historical growth of this market.

The market for treating canine arthritis is projected to experience robust expansion in the forthcoming years. A compound annual growth rate (CAGR) of 5.4% is anticipated, which will propel the market to reach $3.06 billion by 2029. Factors contributing to this projected growth within the forecast period include an increase in pet insurance adoption, a surge in arthritis cases, escalating numbers of pet owners, a rising demand for less invasive surgical treatments, and a higher incidence of arthritis within the canine population. The forecast period will also likely see trends such as ground-breaking treatment methods, progress in the field of veterinary medicine, the call for improved therapies, the incorporation of technology, and cutting-edge technologies.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16007&type=smp

Which Primay Drivers Are Accelerating Growth in the Canine Arthritis Treatment Market?

The growth of the market for canine arthritis treatment is set to be fuelled by the increasing rates of pet ownership. When we talk about pet ownership, we’re referring to the responsibility and care given by individuals or families to meet the needs, welfare, and companionship of domestic animals that are primarily kept for enjoyment rather than practicality. Changes in lifestyle, the trend to humanize pets, and increases in discretionary income are amongst the factors causing an upsurge in pet ownership rates. To manage and relieve the symptoms of arthritis in their dogs, pet owners turn to canine arthritis treatments, with the objective of enhancing their pets’ quality of life and keeping them mobile. As an example, data from the American Pet Products Association, a not-for-profit organization based in the US, in October 2023 indicated that 86.9 million US households had a pet, representing 66% of all households in 2022. Consequently, the escalating rate of pet ownership is a driving force behind the growth of the canine arthritis treatment market.

Which Primary Segments of the Canine Arthritis Treatment Market Are Driving Growth and Industry Transformations?

The canine arthritis treatment market covered in this report is segmented –

1) By Treatment Type: Drugs, Supplements, Surgical Procedures, Other Treatment Types

2) By Route Of Administration: Oral, Parenteral, Other Routes Of Administrations

3) By Arthritis Type: Osteoarthritis, Rheumatoid Arthritis, Osteochondrosis, Traumatic Arthritis

4) By Distribution Channels: Veterinary Clinics And Hospitals, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By Drugs: Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Disease-Modifying Osteoarthritis Drugs (DMOADs), Corticosteroids, Analgesics And Pain Relievers

2) By Supplements: Glucosamine And Chondroitin Supplements, Omega-3 Fatty Acids And Fish Oil, Hyaluronic Acid Supplements, MSM (Methylsulfonylmethane) Supplements, Collagen-Based Supplements

3) By Surgical Procedures: Joint Replacement Surgery, Arthroscopy, Osteotomy, Synovectomy

4) By Other Treatment Types: Physical Therapy, Stem Cell Therapy, Platelet-Rich Plasma (PRP) Therapy, Cold Laser Therapy (Low-Level Laser Therapy), Acupuncture

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=16007&type=smp

Which Regions Are Key Players in the Growth of the Canine Arthritis Treatment Market?

North America was the largest region in the canine arthritis treatment market in 2024. Asia-Pacifica is expected to be the fastest-growing region in the forecast period. The regions covered in the canine arthritis treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Which Emerging Trends that Are Influencing the Canine Arthritis Treatment Industry Evolution?

Leading firms in the canine arthritis treatment market are spearheading the creation of new remedies such as bedinvetmab injections to improve joint health and movement in dogs. Bedinvetmab is a type of monoclonal antibody injection which neutralizes the nerve growth factor (NGF), a pain-related protein in veterinary medicine. In May 2023, Zoetis Inc., an American animal health corporation, gained the Food and Drug Administration’s (FDA) approval for Librela, an injectable form of bedinvetmab. This product is a breakthrough as the first FDA-approved monoclonal antibody (mAb) for canine use, functioning by controlling the biological activity of canine nerve growth factor (NGF) which contributes to osteoarthritis (OA) pain. Librela is easily administered by subcutaneous injection on a monthly basis, offering a convenient and prolonged means for managing OA pain in dogs.

View the full report here:

https://www.thebusinessresearchcompany.com/report/canine-arthritis-treatment-global-market-report

What Parameters Are Used to Define the Canine Arthritis Treatment Market?

Canine arthritis treatment refers to the medical and therapeutic approaches for canine arthritis disease, a chronic condition characterized by inflammation and progressive deterioration of the cartilage within a dog’s joints. It is used to reduce pain and inflammation, maintain joint function, and slow the progression of the disease in dogs.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16007

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

What Are the Primary Drivers Supporting the Market Growth of theCanine Arthritis Treatment Market?

The expected surge in pet ownership is anticipated to fuel the expansion of the canine arthritis treatment market. Pet ownership signifies the dedication and care from individuals or households for the welfare, needs, and companionship of pets, primarily kept for pleasure. Factors such as alterations in lifestyle, the humanization of pets, and increased disposable incomes have contributed to the rise in pet ownership rates. Pet owners employ canine arthritis treatments to manage and reduce the discomfort of arthritis in their dogs, with the goal of enhancing their pets’ quality of life and preserving their mobility. The American Pet Products Association, a US-based non-profit association, reported that in October 2023, there were 86.9 million pet-owning households in the US, equating to 66% of households in 2022. Hence, the surge in pet ownership is positively impacting the growth of the canine arthritis treatment market.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16007&type=smp

#What Are the Key Projections for the CAGR of the Canine Arthritis Treatment Market From 2025 to 2034?

The market for treating canine arthritis has seen robust growth in the recent past. It is set to expand from a size of $2.35 billion in 2024 to roughly $2.48 billion in 2025, recording a compound annual growth rate (CAGR) of 5.6%. Factors contributing to the growth during the historic period include an older pet demographic, heightened awareness amongst pet owners, an emphasis on preventative care, a rise in disposable income and greater expenditure on veterinary care.

In the coming years, the market size for canine arthritis treatment is predicted to experience significant gains. By 2029, it is projected to reach $3.06 billion with a compound annual growth rate (CAGR) of 5.4%. Factors contributing to this forecasted growth include increased pet insurance coverage, an escalation in arthritis cases, higher pet ownership, a surge in the preference for less invasive surgical methods, and a rising incidence of arthritis in dogs. Key trends for the period include innovative treatment options, progress in veterinary science, demand for advanced therapy methods, technology integration, and innovative techniques.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16007

What Are the Latest Innovations Influencing theCanine Arthritis Treatment Market?

In the canine arthritis therapy industry, leading firms are establishing groundbreaking treatments such as bedinvetmab injections, aimed at enhancing joint health and mobility in dogs. Bedinvetmab, a type of monoclonal antibody injection, operates by identifying and neutralizing nerve growth factor (NGF), a protein that plays a part in pain relief in veterinary medicine. For instance, Zoetis Inc., an animal health firm based in the US, was granted approval by the Food and Drug Administration (FDA) in May 2023 for Librela, a bedinvetmab injection. This is the first FDA-approved monoclonal antibody (mAb) for usage in dogs, and it functions by adhering to and inhibiting the biological function of canine NGF, a protein involved in managing pain related to OA. Administered subcutaneously once a month, it serves as an efficient and long-lasting alternative for managing pain brought on by canine OA.

Who Are the Major Industry Players Accelerating Growth in theCanine Arthritis Treatment Market?

Major companies operating in the canine arthritis treatment market are Merck & Co. Inc., Bayer AG, Eli Lilly and Company, Zoetis Inc., Boehringer Ingelheim Animal Health, Elanco Animal Health Incorporated, Royal Canin SAS, Virbac Group, Ceva Sante Animale S.A., Hill’s Pet Nutrition Inc., Vetoquinol SA, Norbrook Laboratories Limited, American Regent Inc., Thorne Healthtech Inc., VetStem Inc., Eltech K-Laser s.r.l., Liquid Health Inc, Nutri-Vet LLC, OrthoPets LLC, Rejuvenate Bio Inc.

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/canine-arthritis-treatment-global-market-report

Which Primary Segments of the Canine Arthritis Treatment Market Are Driving Growth and Industry Transformations?

The canine arthritis treatment market covered in this report is segmented –

1) By Treatment Type: Drugs, Supplements, Surgical Procedures, Other Treatment Types

2) By Route Of Administration: Oral, Parenteral, Other Routes Of Administrations

3) By Arthritis Type: Osteoarthritis, Rheumatoid Arthritis, Osteochondrosis, Traumatic Arthritis

4) By Distribution Channels: Veterinary Clinics And Hospitals, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By Drugs: Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Disease-Modifying Osteoarthritis Drugs (DMOADs), Corticosteroids, Analgesics And Pain Relievers

2) By Supplements: Glucosamine And Chondroitin Supplements, Omega-3 Fatty Acids And Fish Oil, Hyaluronic Acid Supplements, MSM (Methylsulfonylmethane) Supplements, Collagen-Based Supplements

3) By Surgical Procedures: Joint Replacement Surgery, Arthroscopy, Osteotomy, Synovectomy

4) By Other Treatment Types: Physical Therapy, Stem Cell Therapy, Platelet-Rich Plasma (PRP) Therapy, Cold Laser Therapy (Low-Level Laser Therapy), Acupuncture

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=16007&type=smp

Which Regions Are Key Players in the Growth of the #What Are the Primary Drivers Supporting the Market Growth of theCanine Arthritis Treatment Market?# Market?

North America was the largest region in the canine arthritis treatment market in 2024. Asia-Pacifica is expected to be the fastest-growing region in the forecast period. The regions covered in the canine arthritis treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Reports Similar to the Global Canine Arthritis Treatment Market 2025, By The Business Research Company:

Gastrointestinal Bleeding Treatment Devices Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/gastrointestinal-bleeding-treatment-devices-global-market-report

Psoriatic Arthritis Treatment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/psoriatic-arthritis-treatments-global-market-report

Point-of-Use Water Treatment Systems Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/point-of-use-water-treatment-systems-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What fueled the previous growth in the canine arthritis treatment market?

The canine arthritis treatment market has grown strongly in recent years. It will expand from $2.35 billion in 2024 to $2.48 billion in 2025, at a compound annual growth rate (CAGR) of 5.6%. Growth is due to the aging pet population, heightened awareness among pet owners, focus on preventive care, higher disposable income, and growing expenditure on veterinary care.

What will be the canine arthritis treatment market size in the future?

The canine arthritis treatment market is forecasted to grow to $3.06 billion by 2029, at a CAGR of 5.4%. The growth is attributed to a rise in pet insurance coverage, increasing arthritis cases, higher pet ownership, demand for minimally invasive procedures, and the growing prevalence of arthritis in dogs. Trends include innovative treatments, advancements in veterinary medicine, demand for advanced therapies, the integration of technology, and emerging innovative technologies.

Get your canine arthritis treatment market report here!

https://www.thebusinessresearchcompany.com/report/canine-arthritis-treatment-global-market-report

What main drivers are fueling expansion in the canine arthritis treatment market?

The rising rate of pet ownership is expected to boost the canine arthritis treatment market. As more people own pets, the demand for arthritis treatments for dogs is increasing. The American Pet Products Association reported that 66% of U.S. households owned pets in 2022, supporting the growth of this market.

What key areas define the segmentation of the global canine arthritis treatment market?

The canine arthritis treatment market covered in this report is segmented –

1) By Treatment Type: Drugs, Supplements, Surgical Procedures, Other Treatment Types

2) By Route Of Administration: Oral, Parenteral, Other Routes Of Administrations

3) By Arthritis Type: Osteoarthritis, Rheumatoid Arthritis, Osteochondrosis, Traumatic Arthritis

4) By Distribution Channels: Veterinary Clinics And Hospitals, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By Drugs: Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Disease-Modifying Osteoarthritis Drugs (DMOADs), Corticosteroids, Analgesics And Pain Relievers

2) By Supplements: Glucosamine And Chondroitin Supplements, Omega-3 Fatty Acids And Fish Oil, Hyaluronic Acid Supplements, MSM (Methylsulfonylmethane) Supplements, Collagen-Based Supplements

3) By Surgical Procedures: Joint Replacement Surgery, Arthroscopy, Osteotomy, Synovectomy

4) By Other Treatment Types: Physical Therapy, Stem Cell Therapy, Platelet-Rich Plasma (PRP) Therapy, Cold Laser Therapy (Low-Level Laser Therapy), Acupuncture

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16007&type=smp

Who are the dominant players expanding their reach in the canine arthritis treatment market?

Major companies operating in the canine arthritis treatment market are Merck & Co. Inc., Bayer AG, Eli Lilly and Company, Zoetis Inc., Boehringer Ingelheim Animal Health, Elanco Animal Health Incorporated, Royal Canin SAS, Virbac Group, Ceva Sante Animale S.A., Hill’s Pet Nutrition Inc., Vetoquinol SA, Norbrook Laboratories Limited, American Regent Inc., Thorne Healthtech Inc., VetStem Inc., Eltech K-Laser s.r.l., Liquid Health Inc, Nutri-Vet LLC, OrthoPets LLC, Rejuvenate Bio Inc.

How are evolving market trends shaping canine arthritis treatment Strategies?

In the canine arthritis treatment market, companies are developing innovative solutions like bedinvetmab injections to improve joint health in dogs. For instance, in May 2023, Zoetis Inc., a US-based animal health company, received FDA approval for Librela, a bedinvetmab injection designed for managing osteoarthritis pain in dogs. This first-ever monoclonal antibody treatment for canine osteoarthritis offers a monthly subcutaneous injection to target and neutralize the pain-causing nerve growth factor (NGF), providing long-term pain relief.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16007

Which regions are emerging as leaders in the canine arthritis treatment market?

North America was the largest region in the canine arthritis treatment market in 2024. Asia-Pacifica is expected to be the fastest-growing region in the forecast period. The regions covered in the canine arthritis treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Gastrointestinal Bleeding Treatment Devices Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/gastrointestinal-bleeding-treatment-devices-global-market-report

Psoriatic Arthritis Treatment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/psoriatic-arthritis-treatments-global-market-report

Point-of-Use Water Treatment Systems Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/point-of-use-water-treatment-systems-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: